Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma.

Kim N, Chang JS, Wee CW, Kim IA, Chang JH, Lee HS, Kim SH, Kang SG, Kim EH, Yoon HI, Kim JW, Hong CK, Cho J, Kim E, Kim TM, Kim YJ, Park CK, Kim JW, Kim CY, Choi SH, Kim JH, Park SH, Choe G, Lee ST, Kim IH, Suh CO.

Strahlenther Onkol. 2019 Sep 5. doi: 10.1007/s00066-019-01512-y. [Epub ahead of print]

PMID:
31489457
2.

A Comparative Analysis of the Usefulness of Survival Prediction Models for Patients with Glioblastoma in the Temozolomide Era: The Importance of Methylguanine Methyltransferase Promoter Methylation, Extent of Resection, and Subventricular Zone Location.

Woo P, Ho J, Lam S, Ma E, Chan D, Wong WK, Mak C, Lee M, Wong ST, Chan KY, Poon WS.

World Neurosurg. 2018 Jul;115:e375-e385. doi: 10.1016/j.wneu.2018.04.059. Epub 2018 Apr 17.

PMID:
29678708
3.

An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.

Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJC, Penas-Prado M, Youssef E, Blumenthal DT, Zhang P, Mehta MP, Barnholtz-Sloan JS.

Neuro Oncol. 2017 May 1;19(5):669-677. doi: 10.1093/neuonc/now208.

4.

Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation.

Molitoris JK, Rao YJ, Patel RA, Kane LT, Badiyan SN, Gittleman H, Barnholtz-Sloan JS, Bentzen SM, Kruser TJ, Huang J, Mehta MP.

J Neurooncol. 2017 Sep;134(2):331-338. doi: 10.1007/s11060-017-2529-2. Epub 2017 Jun 22.

PMID:
28643151
5.

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.

Bell EH, Pugh SL, McElroy JP, Gilbert MR, Mehta M, Klimowicz AC, Magliocco A, Bredel M, Robe P, Grosu AL, Stupp R, Curran W Jr, Becker AP, Salavaggione AL, Barnholtz-Sloan JS, Aldape K, Blumenthal DT, Brown PD, Glass J, Souhami L, Lee RJ, Brachman D, Flickinger J, Won M, Chakravarti A.

JAMA Oncol. 2017 Jun 1;3(6):784-792. doi: 10.1001/jamaoncol.2016.6020.

6.

An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival.

Gittleman H, Cioffi G, Chunduru P, Molinaro AM, Berger MS, Sloan AE, Barnholtz-Sloan JS.

Neurooncol Adv. 2019 May-Dec;1(1):vdz007. doi: 10.1093/noajnl/vdz007. Epub 2019 May 30.

7.

Predicting individual survival after potentially curative esophagectomy for adenocarcinoma of the esophagus or gastroesophageal junction.

Lagarde SM, Reitsma JB, Ten Kate FJ, Busch OR, Obertop H, Zwinderman AH, Moons J, van Lanschot JJ, Lerut T.

Ann Surg. 2008 Dec;248(6):1006-13. doi: 10.1097/SLA.0b013e318190a0a2.

PMID:
19092345
8.

Prediction of overall survival for metastatic pancreatic cancer: Development and validation of a prognostic nomogram with data from open clinical trial and real-world study.

Hang J, Wu L, Zhu L, Sun Z, Wang G, Pan J, Zheng S, Xu K, Du J, Jiang H.

Cancer Med. 2018 Jun 1. doi: 10.1002/cam4.1573. [Epub ahead of print]

9.

Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram.

Groot Koerkamp B, Wiggers JK, Gonen M, Doussot A, Allen PJ, Besselink MG, Blumgart LH, Busch OR, D'Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, van Gulik TM, Jarnagin WR.

Ann Oncol. 2015 Sep;26(9):1930-5. doi: 10.1093/annonc/mdv279. Epub 2015 Jun 30. Erratum in: Ann Oncol. 2016 Apr;27(4):753.

10.

Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.

Li J, Chen S, Peng S, Liu Y, Xing S, He X, Chen H.

Int J Biol Sci. 2018 Apr 5;14(5):549-556. doi: 10.7150/ijbs.24374. eCollection 2018.

11.

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.

Fakhry C, Zhang Q, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT, Gillison ML.

J Clin Oncol. 2017 Dec 20;35(36):4057-4065. doi: 10.1200/JCO.2016.72.0748. Epub 2017 Aug 4.

12.

Validation of a Nomogram Predicting Survival After Trimodality Therapy for Esophageal Cancer.

Goense L, Merrell KW, Arnett AL, Hallemeier CL, Meijer GJ, Ruurda JP, Hofstetter WL, van Hillegersberg R, Lin SH.

Ann Thorac Surg. 2018 Nov;106(5):1541-1547. doi: 10.1016/j.athoracsur.2018.05.055. Epub 2018 Jun 19.

PMID:
29932887
13.

Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladder.

Nakagawa T, Taguchi S, Uemura Y, Kanatani A, Ikeda M, Matsumoto A, Yoshida K, Kawai T, Nagata M, Yamada D, Komemushi Y, Suzuki M, Enomoto Y, Nishimatsu H, Ishikawa A, Nagase Y, Kondo Y, Tanaka Y, Okaneya T, Hirano Y, Shinohara M, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.

Urol Oncol. 2017 Jul;35(7):457.e15-457.e21. doi: 10.1016/j.urolonc.2016.12.010. Epub 2017 Jan 16.

PMID:
28110856
14.

Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.

Callegaro D, Miceli R, Bonvalot S, Ferguson P, Strauss DC, Levy A, Griffin A, Hayes AJ, Stacchiotti S, Pechoux CL, Smith MJ, Fiore M, Dei Tos AP, Smith HG, Mariani L, Wunder JS, Pollock RE, Casali PG, Gronchi A.

Lancet Oncol. 2016 May;17(5):671-80. doi: 10.1016/S1470-2045(16)00010-3. Epub 2016 Apr 5.

PMID:
27068860
15.

External validation of a multi-institutional retroperitoneal sarcoma nomogram.

Raut CP, Miceli R, Strauss DC, Swallow CJ, Hohenberger P, van Coevorden F, Rutkowski P, Fiore M, Callegaro D, Casali PG, Haas RL, Hayes AJ, Honore C, Cannell AJ, Jakob J, Szacht M, Fairweather M, Pollock RE, Bonvalot S, Gronchi A.

Cancer. 2016 May 1;122(9):1417-24. doi: 10.1002/cncr.29931. Epub 2016 Feb 24.

16.

Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.

Louie AV, Haasbeek CJ, Mokhles S, Rodrigues GB, Stephans KL, Lagerwaard FJ, Palma DA, Videtic GM, Warner A, Takkenberg JJ, Reddy CA, Maat AP, Woody NM, Slotman BJ, Senan S.

Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):82-90. doi: 10.1016/j.ijrobp.2015.05.003. Epub 2015 May 9.

PMID:
26138912
17.

Nomogram for predicting the overall survival of patients with inflammatory breast cancer: A SEER-based study.

Pan X, Yang W, Chen Y, Tong L, Li C, Li H.

Breast. 2019 Oct;47:56-61. doi: 10.1016/j.breast.2019.05.015. Epub 2019 Jul 17.

PMID:
31351202
18.

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Weller M, Cairncross JG, Eisenhauer E, Belanger K, Brandes AA, Allgeier A, Lacombe D, Stupp R.

Lancet Oncol. 2008 Jan;9(1):29-38. Epub 2007 Dec 21.

PMID:
18082451
19.

External validation of the Besançon nomogram in Asian patients with advanced pancreatic cancer receiving second-line chemotherapy: A multi-institute experience in Taiwan.

Yu SM, Lu CH, Liu KH, Chen PT, Chang PH, Hung CY, Hsueh SW, Yeh KY, Chen YY, Hung YS, Chou WC.

Pancreatology. 2019 Nov 4. pii: S1424-3903(19)30764-1. doi: 10.1016/j.pan.2019.11.001. [Epub ahead of print]

PMID:
31711795
20.

External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer.

Polterauer S, Zhou Q, Grimm C, Seebacher V, Reinthaller A, Hofstetter G, Concin N, Leitao MM Jr, Barakat RR, Abu-Rustum NR, Iasonos A.

Gynecol Oncol. 2012 Jun;125(3):526-30. doi: 10.1016/j.ygyno.2012.03.030. Epub 2012 Mar 23.

Supplemental Content

Support Center